A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations
It's pretty funny to me that when we were growing up, she'd cry because she wasn't allowed to play football with us.One of my favorite paintings was done in 1962 by Bill Dodge.There is a water scene that I really like painted in 1940. It's called Alligator Fisher and I'm thinking about getting because it reminds me of my cajun heritage, most of my family is from Louisiana. Now we're very close. Still, they are a joy to behold. When she died, she left me the painting and it hangs in a place of honor over my fireplace mantle.There is a subcategory of folk art paintings since I was a child. I have a friend who collects these and I found one of a woman reclining in a hammock.The painting that has touched me the most features a sad little girl and is called A Letter From My Mother. It's of a swamp house on a bayou and has a Louisiana feel to it. It was painted in 1988 by Reverend Howard Finster and is done in enamel. She looked so relaxed, that I could imagine what it felt like to lie there myself. I saw a painting he did of a fishing scene but.....

"Written by Petra Rattue Copyright: Medical News TodayNot to be reproduced without permission of Medical News Today Additional References Citations . Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs. The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers. However, it does appear to increase the risk of skin cancer, including melanoma. The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010. It's a beautiful painting but it's just too depressing to hang anywhere. It is done in vibrant colors and also depicts the buildings in the market like an ice cream parlor and the Hotel Van Nuys. It's called Alligator Fisher and I'm thinking about getting because it reminds me of my cajun heritage, most of my family is from Louisiana. She favors animal prints, and I found one that depicts leopards and gave it to her for her birthday. Now we're very close.The painting that has touched me the most features a sad little girl and is called A Letter From My Mother.There is a water scene that I really like painted in 1940.I have loved folk art paintings since I was a child.My sister also shares my love for folk art. It's too bad my parents didn't let her play football with us. It was painted in 1988 by Reverend Howard Finster and is done in enamel..Another painting that I admire is called Howard in 1944. I don't know whose smile is bigger, the one in the painting or the one on my face every time I look at it. I personally don't have any of these in my collection, since I like to collect pieces that I can relate to. One of my favorites that she had was done by John Roeder. It's pretty funny to me that when we were growing up, she'd cry because she wasn't allowed to play football with the boys and I used to tease her relentlessly and pull her pigtails whenever I got the chance. When she died, she left me the painting and it hangs in a place of honor over my fireplace mantle. She looked so relaxed, that I could imagine what

rthritis types athritis types arhritis types artritis types arthitis types arthrtis types arthriis types arthrits types arthriti types arthritis ypes arthritis tpes arthritis tyes arthritis typs arthritis type srthritis types aethritis types atthritis types arrhritis types aryhritis types artgritis types artjritis types artheitis types arthtitis types arthrutis types arthrotis types arthriris types arthriyis types arthritus types arthritos types arthritia types arthritid types arthritis rypes arthritis yypes arthritis ttpes arthritis tupes arthritis tyoes arthritis typws arthritis typrs arthritis typea arthritis typed rathritis types atrhritis types arhtritis types artrhitis types arthirtis types arthrtiis types arthriits types arthritsi types arthriti stypes arthritis ytpes arthritis tpyes arthritis tyeps arthritis typse arthritis type aarthritis types arrthritis types artthritis types arthhritis types arthrritis types arthriitis types arthrittis types arthritiis types arthritiss types arthritis ttypes arthritis tyypes arthritis typpes arthritis typees arthritis typess
A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer. Inflammatory arthritis has been associated with an increased risk of some types of cancers, in particular with lymphoma and lung cancer but with a lower risk of other cancer types, such as bowel and breast cancers.

Researchers set out to clarify whether tumor necrosis factor (TNF) inhibitors, i.e. drugs acting on the immune system, might affect the risk of cancer, by evaluating several clinical research databases, findings presented to the American College of Rheumatology, the European League against Rheumatism, and the British Society for Rheumatology between 1998 and 2010.

The findings were based on 21 studies and 8 conference abstracts, all complying to the strict inclusion criteria of reporting data on cancer linked to TNF inhibitors, including the monoclonal antibodies infliximab and adalimumab and the protein etanercept. In total researchers collated information on over 40,000 patients and nearly 150,000 cumulative years of exposure to these drugs.

The combined risk from seven studies for the development of any cancer revealed negligible or no increased risk, overall.

Two studies also showed no evidence of an increased cancer risk in patients taking TNF inhibitors over long-term, however, those previously diagnosed with cancer had a higher chance of being re-diagnosed with the disease, although this was not due to using TNF inhibitors.

Four studies revealed that patients treated with TNF inhibitors had a 45% higher chance of developing skin cancer other than melanoma, whereas two studies showed, that patients taking TNF inhibitors had a 79% increased risk of developing a melanoma compared with those who did not take these drugs.

The authors conclude:

"This systematic review and meta analysis provides reassurance to physicians and patients that the treatment of [rheumatoid arthritis] with TNF inhibitors does not increase the risk of malignancy, particularly lymphoma. However, it does appear to increase the risk of skin cancer, including melanoma."


Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations